Related Experiment Video

Updated: Aug 22, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Differential regulation of MAPK (JNK 3) gene expression in human head and neck squamous cell carcinomas

T Görögh1, J Berwig, N Scola

  • 1Klinik für HNO-Heilkunde, Kopf- und Halschirurgie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.

Onkologie
|September 7, 2004
PubMed
Abstract

Insights

The JNK 3 gene, involved in cell signaling, shows significantly reduced expression in head and neck squamous cell carcinoma (HNSCC). This repression suggests JNK 3 plays a role in head and neck cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • The JNK 3 gene encodes a protein within the mitogen-activated protein (MAP) kinase family, crucial for cellular signaling pathways.
  • MAP kinases are integral to understanding cellular responses and disease mechanisms.

Purpose of the Study:

  • To investigate the expression levels of JNK 3 in head and neck squamous cell carcinoma (HNSCC).
  • To determine the potential role of JNK 3 in the carcinogenic processes of HNSCC.

Main Methods:

  • Messenger RNA (mRNA) was extracted from HNSCC cells and normal keratinocytes.
  • Arbitrarily primed mRNA fingerprinting and Northern hybridization were employed to analyze gene expression.
  • cDNA was generated via reverse transcription for subsequent analysis.

Main Results:

  • A specific 107 bp mRNA fragment homologous to JNK 3 was identified.
  • JNK 3 expression was found to be significantly repressed in HNSCC cells compared to normal cells.
  • Northern hybridization confirmed reduced JNK 3 gene expression in HNSCC biopsies.

Conclusions:

  • Evidence indicates strong repression of JNK 3 gene expression in HNSCC.
  • The findings suggest JNK 3 is implicated in the development of head and neck cancer.
  • JNK 3 may serve as a potential biomarker or therapeutic target in HNSCC.

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...